Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.

HALT spectacle lenses can significantly reduce myopic progression independently from, or as a supplement to, low-dose atropine.

The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

Using regression analysis, the investigators found that the control of axial growth with ortho-K treatment was better in the summer than in the winter (β=-0.05; P <.001). They observed a similar ...

Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.